PURPOSE: We aimed to investigate the safety and effectiveness of intracranial stenting in a population with severe (≥ 70%) symptomatic intracranial internal carotid artery (ICA) atherosclerotic stenosis. METHODS: Fifty-eight patients with severe intracranial ICA atherosclerotic stenosis were prospectively enrolled. The baseline data, cerebral angiography, success rate, perioperative complications, clinical and imaging follow-up were prospectively analyzed. RESULTS: All patients had successful intracranial stenting (100%), and the mean degree of stenosis was improved from 84.3% ± 7.5% to 23.5% ± 5.1% after the stent procedure. During the 30-day perioperative period, only one patient (1.7%) had ischemic stroke. Seven patients (12.1%) had headache and dysphoria. Thirty-six patients (62.1%) had clinical follow-up for 6-68 months after stenting. Five female patients (13.9%) had ipsilateral stroke including one death, but no disabling stroke, while three other patients (8.3%) had ipsilateral temporary ischemic attack (TIA). The recurrent stroke rate was higher in patients presenting with stroke (4/17, 23.5%) than in patients presenting with TIA (1/19, 5.3%), with no statistical significance (P = 0.33). Thirteen patients (22.4%) had imaging follow-up of 5-12 months following stenting, five of whom (38.5%) had in-stent restenosis. CONCLUSION: Intracranial stenting for patients with intracranial ICA atherosclerotic stenosis has a low perioperative stroke rate and decent outcome on long-term follow-up, despite a relatively high in-stent restenosis rate.
PURPOSE: We aimed to investigate the safety and effectiveness of intracranial stenting in a population with severe (≥ 70%) symptomatic intracranial internal carotid artery (ICA) atherosclerotic stenosis. METHODS: Fifty-eight patients with severe intracranial ICA atherosclerotic stenosis were prospectively enrolled. The baseline data, cerebral angiography, success rate, perioperative complications, clinical and imaging follow-up were prospectively analyzed. RESULTS: All patients had successful intracranial stenting (100%), and the mean degree of stenosis was improved from 84.3% ± 7.5% to 23.5% ± 5.1% after the stent procedure. During the 30-day perioperative period, only one patient (1.7%) had ischemic stroke. Seven patients (12.1%) had headache and dysphoria. Thirty-six patients (62.1%) had clinical follow-up for 6-68 months after stenting. Five female patients (13.9%) had ipsilateral stroke including one death, but no disabling stroke, while three other patients (8.3%) had ipsilateral temporary ischemic attack (TIA). The recurrent stroke rate was higher in patients presenting with stroke (4/17, 23.5%) than in patients presenting with TIA (1/19, 5.3%), with no statistical significance (P = 0.33). Thirteen patients (22.4%) had imaging follow-up of 5-12 months following stenting, five of whom (38.5%) had in-stent restenosis. CONCLUSION: Intracranial stenting for patients with intracranial ICA atherosclerotic stenosis has a low perioperative stroke rate and decent outcome on long-term follow-up, despite a relatively high in-stent restenosis rate.
Authors: Karen L Furie; Scott E Kasner; Robert J Adams; Gregory W Albers; Ruth L Bush; Susan C Fagan; Jonathan L Halperin; S Claiborne Johnston; Irene Katzan; Walter N Kernan; Pamela H Mitchell; Bruce Ovbiagele; Yuko Y Palesch; Ralph L Sacco; Lee H Schwamm; Sylvia Wassertheil-Smoller; Tanya N Turan; Deidre Wentworth Journal: Stroke Date: 2010-10-21 Impact factor: 7.914
Authors: A S Turk; E I Levy; F C Albuquerque; G L Pride; H Woo; B G Welch; D B Niemann; P D Purdy; B Aagaard-Kienitz; P A Rasmussen; L N Hopkins; T J Masaryk; C G McDougall; D Fiorella Journal: AJNR Am J Neuroradiol Date: 2007-11-07 Impact factor: 3.825
Authors: O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz Journal: Neurology Date: 2008-01-30 Impact factor: 9.910
Authors: David Fiorella; Colin P Derdeyn; Michael J Lynn; Stanley L Barnwell; Brian L Hoh; Elad I Levy; Mark R Harrigan; Richard P Klucznik; Cameron G McDougall; G Lee Pride; Osama O Zaidat; Helmi L Lutsep; Michael F Waters; J Maurice Hourihane; Andrei V Alexandrov; David Chiu; Joni M Clark; Mark D Johnson; Michel T Torbey; Zoran Rumboldt; Harry J Cloft; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz Journal: Stroke Date: 2012-09-13 Impact factor: 7.914
Authors: Colin P Derdeyn; Marc I Chimowitz; Michael J Lynn; David Fiorella; Tanya N Turan; L Scott Janis; Jean Montgomery; Azhar Nizam; Bethany F Lane; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; John R Lynch; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft Journal: Lancet Date: 2013-10-26 Impact factor: 79.321
Authors: Felipe C Albuquerque; Elad I Levy; Aquilla S Turk; David B Niemann; Beverly Aagaard-Kienitz; G Lee Pride; Phillip D Purdy; Babu G Welch; Henry H Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall; David J Fiorella Journal: Neurosurgery Date: 2008-07 Impact factor: 4.654